Morgan Stanley Stock News

We are updating our 5-year earnings roadmap, with higher assumptions for some of the auto and surveillance categories. We have been surprised by the move in the stock, but see it as synchronized with other high growth names, and we see January CES as an important catalyst. Remain Overweight, Price Target higher, noted Joseph Moore, equity analyst at Morgan Stanley.

Morgan Stanley CEO James Gorman had said this summer that he would have been "very disappointed" if employees hadn''t

Adagio Therapeutics Inc (NASDAQ: ADGI) was up more than 75% on Monday after the biotech firm said Omicron was unlikely to be more resistant against its investigational monoclonal antibody, ADG20, despite a record number of mutations. Morgan Stanley raised its price target on ADGI The stock further got a boost as Morgan Stanley upgraded it [] The post Morgan Stanley: Omicron will benefit this relatively new biotech firm appeared first on Invezz .

Pfizer (NYSE:PFE) had its price target upped by equities researchers at Morgan Stanley from $50.00 to $60.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an equal weight rating on the biopharmaceutical companys stock. Morgan Stanleys price objective indicates a potential upside of 11.11% from the companys previous close. []

Nisa Investment Advisors LLC reduced its position in shares of Morgan Stanley (NYSE:MS) by 0.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 507,038 shares of the financial services providers stock after selling 2,307 shares during the period. Nisa Investment Advisors []

The news of a new variant of the coronavirus Friday sent financial markets into a tailspin. The adversity could present an opportunity for a handful of biopharma stocks, according to a Morgan Stanley analyst. The Biopharma Analyst: Matthew Harrison maintained an Equal-Weight rating on Pfizer, Inc. (NYSE: PFE ) shares and increased the price target from $50 to $60. The analyst maintained an Equal-Weight rating on Merck & Co., Inc. (NYSE: MRK ) shares and reduced the price target from $88 to $82. Harrison upgraded shares of Adagio Therapeutics, Inc. (NASDAQ: ADGI ) from Equal-Weight to Overweight and lifted the price target from $33 to $49. The Biopharma Thesis: Omicron highlights the continued variant risk in an evolving pandemic and it is likely to replace the delta variant, increasing infection rates and reducing vaccine effectiveness, Harrison said in a note. Transmission appears to be the significant difference, as reflected by the proportion of sequenced cases pointing to omicron overtaking delta and the faster rate at which it has reached a high proportion of local cases relative to other key

Shift4 Payments, Inc. (NYSE:FOUR)s stock price hit a new 52-week low on Monday . The company traded as low as $50.80 and last traded at $50.93, with a volume of 12627 shares traded. The stock had previously closed at $54.11. Several research firms have recently commented on FOUR. Morgan Stanley reduced their target price on []

Morgan Stanley analyst Luke Holbrook assumed Jumia Technologies AG (NYSE: JMIA ) at Underweight with an $11 price

NuWave Investment Management LLC purchased a new stake in Morgan Stanley (NYSE:MS) during the 3rd quarter, HoldingsChannel.com reports. The firm purchased 5,168 shares of the financial services providers stock, valued at approximately $503,000. A number of other institutional investors have also recently bought and sold shares of MS. Colony Group LLC boosted its holdings in []

SoFi Technologies, Inc. (NASDAQ:SOFI)s share price gapped up before the market opened on Monday . The stock had previously closed at $18.21, but opened at $19.18. SoFi Technologies shares last traded at $17.93, with a volume of 133,125 shares trading hands. Several analysts have commented on the stock. Morgan Stanley assumed coverage on shares of []

Hargreaves Lansdown (OTCMKTS:HRGLY) was downgraded by equities researchers at Morgan Stanley to an “underweight” rating in a research note issued to investors on Monday, The Fly reports. Other equities analysts have also issued research reports about the stock. JPMorgan Chase & Co. restated an “underweight” rating on shares of Hargreaves Lansdown in a research report […]

LAS VEGAS, Nov. 29, 2021 /PRNewswire/ -- MGM Resorts International (NYSE: MGM) will participate in Morgan Stanley''s Virtual Global Consumer & Retail Conference on Wednesday, December 1, 2021. MGM Resorts CFO Jonathan Halkyard will also speak at a session scheduled to begin at 1:40 p.m.

Corporate

Extra Space Storage (NYSE:EXR) had its price objective raised by stock analysts at Morgan Stanley from $160.00 to $175.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has an underweight rating on the real estate investment trusts stock. Morgan Stanleys target price would indicate a potential downside of 11.97% []